⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARWR News
Arrowhead Research Corporation
Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA
globenewswire.com
CDXS
CRSP
ARWR
WVE
Dementia Associated With Alzheimer's Disease Market Research Report 2026: Overview of Over 80 Companies and More Than 100 Pipeline Drugs
globenewswire.com
MRK
ARWR
Oligonucleotides Clinical Trial Drug Development Pipeline Expands with Contributions from 200+ Key Companies | DelveInsight
globenewswire.com
IONS
ALNY
NVS
BIIB
ARWR
SLN
WVE
VNDA
NSP
TCRT
AMX
CDIO
SRPT
VIR
BNTX
ARCT
GSK
PFE
Wall Street's Cardiac Bet: Where Diagnostics Meet the Money
prnewswire.com
BBIO
BMY
ARWR
AMGN
Form 8-K
sec.gov
ARWR
Arrowhead Pharmaceuticals Reports Fiscal 2026 Second Quarter Results
businesswire.com
ARWR
Arrowhead Pharmaceuticals Receives TGA Approval of REDEMPLO® (plozasiran) in Australia, Expanding Global Access for Patients with Familial Chylomicronemia Syndrome (FCS)
businesswire.com
ARWR
Complement Inhibitors Market Outlook Remains Strong During the Forecast Period (2026–2036) with Increasing Adoption of C5 and C3 Targeted Drugs | DelveInsight
globenewswire.com
AZN
IONS
ARWR
REGN
SNY
OMER
IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight
globenewswire.com
NVS
VRTX
BIIB
VTRS
AZN
IONS
TAK
ARWR
WLDN
Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Second Quarter Results
businesswire.com
ARWR